1. Home
  2. XTNT vs IMUX Comparison

XTNT vs IMUX Comparison

Compare XTNT & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XTNT
  • IMUX
  • Stock Information
  • Founded
  • XTNT N/A
  • IMUX 2016
  • Country
  • XTNT United States
  • IMUX United States
  • Employees
  • XTNT N/A
  • IMUX N/A
  • Industry
  • XTNT Biotechnology: Biological Products (No Diagnostic Substances)
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • XTNT Health Care
  • IMUX Health Care
  • Exchange
  • XTNT Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • XTNT 60.9M
  • IMUX 90.4M
  • IPO Year
  • XTNT N/A
  • IMUX N/A
  • Fundamental
  • Price
  • XTNT $0.63
  • IMUX $0.90
  • Analyst Decision
  • XTNT
  • IMUX Strong Buy
  • Analyst Count
  • XTNT 0
  • IMUX 5
  • Target Price
  • XTNT N/A
  • IMUX $7.50
  • AVG Volume (30 Days)
  • XTNT 69.9K
  • IMUX 1.2M
  • Earning Date
  • XTNT 08-12-2025
  • IMUX 08-07-2025
  • Dividend Yield
  • XTNT N/A
  • IMUX N/A
  • EPS Growth
  • XTNT N/A
  • IMUX N/A
  • EPS
  • XTNT N/A
  • IMUX N/A
  • Revenue
  • XTNT $127,766,000.00
  • IMUX N/A
  • Revenue This Year
  • XTNT $12.68
  • IMUX N/A
  • Revenue Next Year
  • XTNT $5.40
  • IMUX N/A
  • P/E Ratio
  • XTNT N/A
  • IMUX N/A
  • Revenue Growth
  • XTNT 15.16
  • IMUX N/A
  • 52 Week Low
  • XTNT $0.33
  • IMUX $0.56
  • 52 Week High
  • XTNT $0.78
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • XTNT 51.87
  • IMUX 49.56
  • Support Level
  • XTNT $0.57
  • IMUX $0.89
  • Resistance Level
  • XTNT $0.70
  • IMUX $1.01
  • Average True Range (ATR)
  • XTNT 0.05
  • IMUX 0.08
  • MACD
  • XTNT 0.01
  • IMUX -0.01
  • Stochastic Oscillator
  • XTNT 57.31
  • IMUX 33.80

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: